GlassScriptPhysician profile
Matthew M Buchanan
NPI 1326044298
$16,842.29
in general payments reported to CMS, 2019-2025
27 companies · $6,969 in 2025
The $6,969 reported for 2025 was more than what 76% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $301 · 2021: $8,321 · 2022: $333 · 2023: $52.84 · 2024: $410 · 2025: $6,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5,235 · Honoraria: $1,300 · Food and Beverage: $784 · Travel and Lodging: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,234.78 |
| Honoraria | $1,300.00 |
| Food and Beverage | $783.88 |
| Travel and Lodging | $113.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $13,501.22 | 2021-2025 | Arcad, Nexis, Arcad Nitinol Compression Staples |
| Supreme Orthopedic Systems, LLC | $737.27 | 2021-2025 | |
| Arthrex, INC. | $730.26 | 2019-2021 | |
| Exactech, INC. | $321.69 | 2020-2021 | |
| Merete Technologies, INC | $166.75 | 2019-2022 | |
| Nuvasive, INC. | $151.76 | 2022 | |
| In2bones USA, LLC | $144.09 | 2021 | |
| Alpha Orthopedic Systems | $139.41 | 2019 | |
| Orthofix Medical, INC. | $138.83 | 2024-2025 | Accelstim, Physio-Stim |
| Medtronic, INC. | $132.65 | 2022-2025 | Inceptiv |
| Pacira Pharmaceuticals Incorporated | $125.94 | 2024-2025 | Exparel, Zilretta, Iovera |
| Medline Industries LP | $76.40 | 2021 | |
| Integra Lifesciences Corporation | $72.25 | 2019-2024 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Innovation Technologies INC | $56.85 | 2020 | |
| Stryker Corporation | $46.96 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $46.63 | 2024 | Krystexxa |
| Convatec INC. | $42.38 | 2025 | |
| Depuy Synthes Sales INC. | $32.24 | 2025 | Monovisc, Orthovisc |
| Bioventus LLC | $31.17 | 2022 | |
| Lifenet Health | $30.35 | 2019 | |
| Endo USA, INC. | $24.94 | 2024 | Xiaflex |
| Pacira Therapeutics, INC. | $16.72 | 2019 | |
| Smith+Nephew, INC. | $16.53 | 2025 | Pico 7 |
| Vertex Pharmaceuticals Incorporated | $16.10 | 2025 | |
| Astellas Pharma US INC | $15.65 | 2019 | |
| Daiichi Sankyo INC. | $14.12 | 2019 | |
| Linvatec Corporation | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.